IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BOLIS, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.312
NA - Nord America 3.504
AS - Asia 3.004
SA - Sud America 363
AF - Africa 70
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.275
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.415
GB - Regno Unito 1.396
SG - Singapore 939
IT - Italia 935
CN - Cina 866
SE - Svezia 421
RU - Federazione Russa 354
DE - Germania 296
BR - Brasile 258
HK - Hong Kong 236
VN - Vietnam 209
NL - Olanda 203
FR - Francia 183
TR - Turchia 174
UA - Ucraina 141
KR - Corea 127
IN - India 124
BD - Bangladesh 119
FI - Finlandia 113
IE - Irlanda 93
PL - Polonia 56
CA - Canada 53
EU - Europa 52
CO - Colombia 49
JP - Giappone 46
ES - Italia 31
ID - Indonesia 26
AR - Argentina 23
IQ - Iraq 22
CI - Costa d'Avorio 18
TW - Taiwan 18
AU - Australia 16
ZA - Sudafrica 16
MX - Messico 15
PK - Pakistan 15
BE - Belgio 14
TH - Thailandia 13
CH - Svizzera 12
GR - Grecia 11
EC - Ecuador 10
PH - Filippine 10
SA - Arabia Saudita 10
MA - Marocco 9
VE - Venezuela 9
CL - Cile 8
RO - Romania 8
KE - Kenya 7
HU - Ungheria 6
PT - Portogallo 6
UZ - Uzbekistan 6
AT - Austria 5
JM - Giamaica 5
LU - Lussemburgo 5
PA - Panama 5
AO - Angola 4
AZ - Azerbaigian 4
BY - Bielorussia 4
CR - Costa Rica 4
EG - Egitto 4
MY - Malesia 4
OM - Oman 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
IL - Israele 3
IR - Iran 3
JO - Giordania 3
LB - Libano 3
NP - Nepal 3
TN - Tunisia 3
UY - Uruguay 3
BH - Bahrain 2
EE - Estonia 2
KH - Cambogia 2
KZ - Kazakistan 2
MK - Macedonia 2
PY - Paraguay 2
YE - Yemen 2
AG - Antigua e Barbuda 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CM - Camerun 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
HT - Haiti 1
KG - Kirghizistan 1
LV - Lettonia 1
NA - Namibia 1
Totale 11.316
Salva come PNG Salva come JPEG
Città #
Southend 1.222
Singapore 576
Chandler 291
Ashburn 266
Hong Kong 225
Seattle 221
San Jose 217
Milan 201
Beijing 192
Princeton 143
Jacksonville 127
Wilmington 127
Dallas 123
Council Bluffs 105
Dublin 92
Ann Arbor 88
Fairfield 88
Redmond 87
Boardman 78
Los Angeles 73
Santa Clara 73
Bengaluru 68
Nanjing 64
Mountain View 63
Houston 60
Lauterbourg 58
Somerville 58
Woodbridge 58
Sakarya 57
Shanghai 53
Ho Chi Minh City 52
Dearborn 50
Des Moines 47
Serra 47
Rome 46
Moscow 43
Warsaw 43
Bogotá 40
Hanoi 39
Helsinki 36
Andover 35
New York 35
Redwood City 35
Buffalo 33
The Dalles 33
Guangzhou 31
Munich 31
Cangzhou 30
Columbus 27
Nanchang 26
Regina 25
Berlin 23
São Paulo 22
Tianjin 22
Tokyo 22
Shenyang 20
Jinan 19
Abidjan 18
Cambridge 18
Hebei 18
London 18
Changsha 17
Hangzhou 17
Dong Ket 16
Bari 15
Eitensheim 15
Frankfurt am Main 15
Shenzhen 15
Phoenix 14
Prato 14
San Diego 14
Atlanta 13
Da Nang 13
Istanbul 13
Chicago 12
Hefei 12
Jakarta 12
Kunming 12
Fuzhou 11
Nuremberg 11
Toronto 11
Athens 10
Bitonto 10
Lanzhou 10
Montreal 10
Orem 10
Seoul 10
Verona 10
Baghdad 9
Bangkok 9
Jiaxing 9
Taranto 9
Turin 9
Zhengzhou 9
Bologna 8
Brussels 8
Florence 8
Ottawa 8
Polska 8
Taichung 8
Totale 6.582
Salva come PNG Salva come JPEG
Nome #
Manuale di Ginecologia ed Ostetricia 668
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery - The @RISTOS project 556
Serum Levels of 25-Hydroxyvitamin D and Time to Natural Pregnancy 459
Paclitaxel 175 or 225 mg per Meters Squared With Carboplatin in Advanced Ovarian Cancer: A Randomized Trial 440
Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III–IV epithelial ovarian cancer a multicenter, randomized study 388
Vulvar lichen sclerosus : a new regenerative approach through fat grafting 257
Effect of the ethinylestradiol/norelgestromin contraceptive patch on body composition. Results of bioelectrical impedance analysis in a population of Italian women 232
A multicenter, randomized, phase III study comparing paclitaxel/carboplatin (PC) versus topotecan/paclitaxe/carboplatin (TPC) in patients with stage III (residual tumor > 1 cm after primary surgery) and IV ovarian cancer (OC) 200
Serum anti-Müllerian hormone in subfertile women 199
Depleted mitochondrial DNA content in peripheral blood of women with a history of HELLP syndrome 191
Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways 188
Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer–Adjuvant ChemoTherapy in Ovarian Neoplasm Trial 186
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group 184
A Phase I/II Study of Topotecan in Combination with Carboplatin in Recurrent Epithelial Ovarian Cancer 184
A phase I-II trial of high-dose ifosfamide in patients with ovarian cancer refractory or resistant to platinum and/or paclitaxel-containing chemotherapy 184
A role for mitochondria in gestational diabetes mellitus? 179
The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol 172
Survival and prognostic factors of women with advanced ovarian cancer and complete response after a carboplatin-paclitaxel chemotherapy 171
Response and Toxicity to Topotecan in Sensitive Ovarian Cancer Cases with Small Residual Disease after First-Line Treatment with Carboplatinum and Paclitaxel 171
Prevalence of unexpected leiomyosarcoma at myomectomy: a descriptive study 171
Carboplatin Alone vs Carboplatin plus Epidoxorubicin as Second-Line Therapy for Cisplatin- or Carboplatin-Sensitive Ovarian Cancer 169
Patologia preneoplastica del tratto genitale inferiore 169
Procedure for rapid oocyte selection based on quantitative analysis of cumulus cell gene expression 165
Clear cell and papillary serous endometrial carcinomas : survival in a series of 128 cases 164
Topotecan for the treatment of advanced epithelial ovarian cancer : An open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel 163
A phase I-II trial of fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancer 163
p53 Gene Status and Response to Platinum/Paclitaxel-Based Chemotherapy in Advanced Ovarian Carcinoma 160
Compressive suture of the lower uterine segment for the treatment of postpartum hemorrhage due to complete placenta previa : a preliminary study 158
Bleomycin, Methotrexate, and CCNU in Locally Advanced or Recurrent, Inoperable, Squamous-Cell Carcinoma of the Vulva: An EORTC Gynaecological Cancer Cooperative Group Study 157
Paclitaxel vs Epidoxorubicin plus Paclitaxel as Second-Line Therapy for Platinum-Refractory and -Resistant Ovarian Cancer 155
Ten years survival of FIGO stage IIIC epithelial ovarian cancer cases due to lymph node metastases only 155
Determinants of risk of invasive cervical cancer in young women 154
Tumori maligni del tratto genitale inferiore 154
Phase II Trial of Topotecan, Carboplatin, and Paclitaxel as Front-Line Therapy in Suboptimal Advanced Epithelial Ovarian Cancer 151
Fimbrial cells exposure to catalytic iron mimics carcinogenic changes 151
Site of origin of epithelial ovarian cancer: the endometriosis connection 150
A tag-less method for direct isolation of human umbilical vein endothelial cells by gravitational field-flow fractionation 150
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group 148
A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin 146
Case-control study of oestrogen replacement therapy and risk of cervical cancer 145
Clinical Evidence for Topotecan-Paclitaxel Non–Cross-Resistance in Ovarian Cancer 145
Tumori maligni del tratto genitale superiore 145
The incessant menstruation hypothesis : a mechanistic ovarian cancer model with implications for prevention 142
Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer 142
Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer 141
Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group 139
Pelvic and Paraortic Lymph Nodal Status in Advanced Ovarian Cancer and Survival 138
In vitro fertilization and ovarian malignancies : potential implications for the individual patient and for the community 138
Epidoxorubicin versus no treatment as consolidation therapy in advanced ovarian cancer : results from a phase II study 137
International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm Trial: Two Parallel Randomized Phase III Trials of Adjuvant Chemotherapy in Patients With Early-Stage Ovarian Carcinoma 135
Endometriosis and ovarian cancer 134
Survival and prognostic factors of early ovarian cancer 124
Endometriosis and ovarian cancer 124
Hypertrophic donavanosis in a young pregnant woman 122
Malattia trofoblastica gestazionale 120
Determinants of response to a cisplatin-based regimen as neoadjuvant chemotherapy in stage IB-IIB invasive cervical cancer 119
Role of secondary surgery in relapsed ovarian cancer 118
Ovarian cancer risk and history of selected medical conditions linked with female hormones 116
Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy 111
Multimodal approach to ovarian cancer 110
Survival and determinants of response to third-line chemotherapy in sensitive recurrent ovarian cancer patients 101
Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas 99
Survival of advanced ovarian cancer patients with microscopic partial response after surgery and first-line chemotherapy 99
Multifocal endometriosis. A case report 98
Regarding a series of IB bulky cervical cancer treated with neoadjuvant chemotherapy (NACT) and radical hysterectomy and pelvic lymphadenectomy 97
Laparoscopic aspiration of ovarian endometriomas : effect with postoperative gonadotropin releasing hormone agonist treatment 96
Is abdomino-pelvic radiation therapy the optimal treatment for completely resected stage I and II high risk ovarian cancer? 89
Totale 11.786
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.537
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021277 0 0 0 0 0 0 0 0 0 0 215 62
2021/2022591 77 19 14 17 45 64 49 34 33 66 37 136
2022/2023937 106 89 80 137 128 167 6 61 109 9 30 15
2023/2024523 17 56 12 24 65 30 31 80 14 32 76 86
2024/20251.577 56 150 19 157 165 80 141 143 82 196 111 277
2025/20262.978 379 137 290 247 313 240 329 196 349 194 304 0
Totale 11.786